Physiopathological & Therapeutic Value of microRNA in the Progression of

See also
Status	Clinical Trial	Phase
Completed	`NCT03364270` - TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study	Phase 2
Completed	`NCT02781181` - Carotid Artery Stenting Without Protection	N/A
Recruiting	`NCT04431609` - Carotid Web Associated With Cerebral Infarctions

See also

Status

Clinical Trial

Phase

Completed

NCT03364270 - TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study

Phase 2

Completed

NCT02781181 - Carotid Artery Stenting Without Protection

N/A

Recruiting

NCT04431609 - Carotid Web Associated With Cerebral Infarctions

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02804659
Study type	Observational
Source	Centre Hospitalier Universitaire, Amiens
Contact	Pierre MAITRIAS, PhD
Phone	+33 3 22 08 72 67
Email	maitrias.pierre@chu-amiens.fr
Status	Recruiting
Phase
Start date	July 2013
Completion date	March 2019

Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA — CAMIA2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms